Company / Working Capital
TREACE MEDICAL CONCEPTS, INC. Working Capital History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$101.4M
FY2025
5-year range
$101.4M / $153.3M
FY2021-FY2025
Trend
-19.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $153M to $101M over the past 2 years.
Based on SEC 10-K filings.
$101M in FY2025 with a 3-year CAGR of -0.6%.
Declined from $153M to $101M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -0.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -0.6%, indicating a declining trend.
- In FY2025, working capital decreased 19.8% year-over-year.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $101.4M | -19.8% |
| FY2024 | $126.5M | -17.5% |
| FY2023 | $153.3M | +48.6% |
| FY2022 | $103.2M | -13.9% |
| FY2021 | $119.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026